Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Myriad Genetics, Inc. announced that its Board of Directors has set the shareholder of record and distribution dates in connection with the spin–off of its wholly owned subsidiary, Myriad Pharmaceuticals, Inc. Shareholders of record of Myriad Genetics, Inc. on June 2009 will receive on June 2009, a pro–rata dividend of 1/4 share of Myriad Pharmaceuticals, Inc. common stock for each share of Myriad Genetics, Inc. stock. Any fractional shares will be paid in cash.

Today in Popular Press...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/17/09

A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09

Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address